MORGAN STANLEY - ADICET BIO INC ownership

ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 103 filers reported holding ADICET BIO INC in Q3 2022. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ADICET BIO INC
ValueSharesWeighting
Q3 2023$5,255,836
-11.6%
3,836,377
+56.7%
0.00%0.0%
Q2 2023$5,948,259
-37.0%
2,447,843
+49.3%
0.00%0.0%
Q1 2023$9,445,698
-35.3%
1,639,878
+0.5%
0.00%
-50.0%
Q4 2022$14,590,564
-38.2%
1,632,054
-1.7%
0.00%
-33.3%
Q3 2022$23,616,000
-1.0%
1,660,677
+1.6%
0.00%0.0%
Q2 2022$23,853,000
+7877.6%
1,633,737
+10823.6%
0.00%
Q1 2022$299,000
+19.6%
14,956
+4.3%
0.00%
Q4 2021$250,000
+103.3%
14,335
-8.0%
0.00%
Q3 2021$123,000
-20.1%
15,578
+4.3%
0.00%
Q2 2021$154,000
+2466.7%
14,932
+3037.0%
0.00%
Q1 2021$6,000
-97.3%
476
-97.0%
0.00%
Q4 2020$222,000
+93.0%
15,791
+63.3%
0.00%
Q3 2020$115,0009,6700.00%
Other shareholders
ADICET BIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
Abingworth LLP 2,115,385$30,017,00010.26%
Foresite Capital Management V, LLC 680,000$9,670,0007.44%
Foresite Capital Opportunity Management V, LLC 170,000$2,417,0007.26%
DAFNA Capital Management LLC 935,766$13,307,0003.58%
COWEN AND COMPANY, LLC 2,443,246$34,743,0003.32%
JOHNSON & JOHNSON 728,944$10,366,0003.05%
Decheng Capital Management III (Cayman), LLC 580,000$8,248,0002.99%
Ally Bridge Group (NY) LLC 244,400$3,475,0002.29%
Orbimed Advisors 7,447,140$105,898,0001.97%
Cormorant Asset Management, LP 1,400,000$19,908,0001.39%
View complete list of ADICET BIO INC shareholders